USPTO 2015–2025 USPTO PatentsView US Corporation

Vidacare LLC

USPTO PatentsView assignee record - 18 granted patents across 7 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Vidacare ranks #16,494 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 7 technology areas.

#16,494
of 49,997 US assignees by volume
25th percentile
by Innovation Score (27.8/100)
13.8
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16494 · US Corporation #16,494 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 18 grants
  • MID-PACK #16,494/49,997
  • PHOTO-FINISH Vatbox
  • CPC-NARROW A61B · 7 areas
  • INNOV-THIN 27.8/100
  • CLAIMS-RICH 13.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vatbox, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vidacare’s 27.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Vidacare

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vidacare's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Vidacare?

Each dot is one of Vidacare’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vidacare’s own 13.8 claims/patent is at or below the 14.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vidacare vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 17.917.91818.1 051015202530 Granted patents (volume) Avg claims / patent Vr-edu, Inc. - 18, 16.5Vr-eduVatbox, Ltd. - 18, 18.11VatboxVedaBio, Inc. - 18, 27.17VedabioViaLase, Inc. - 18, 22.44VialaseViking Range, LLC - 18, 10.89Viking RangeVirco Mfg. Corporation - 18, 5.5Virco MfgVlaamse Instelling voor Technologisch Onderzoek NV (VITO) - 18, 14.89Vlaamse Instellin…W.C. BRADLEY/ZEBCO Holdings, Inc. - 18, 10.5W C Bradley/Zebco…Vidacare LLC - 18, 13.83Vidacare
Vidacare vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vidacare's grants concentrate

Vidacare LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (10 grants) versus a trough of 2 in 2017. By volume, Vidacare sits between Vr-edu, Inc. and W.C. BRADLEY/ZEBCO Holdings, Inc..

Who files at Vidacare's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Vidacare holds 18 patents at rank #16,498, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Vidacare

By rank, the assignees closest to #16,498 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Vidacare's primary technology class.

Vidacare's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 201520162017 2
USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Vidacare LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 33.3%
2016 10 55.6%
2017 2 11.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Vidacare LLC's patent record in context - here's where to go next.

  • Vidacare LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #16,494 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Vidacare LLC against Vr-edu, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.